Structural properties of a series of photochromic fluorinated indolylfulgides

Fluorinated indolyl­fulgides are a class of photochromic organic compounds that meet many of the requirements for use as optical memory media and optical switches. The X‐ray crystal structures of a series of five photochromic fluorinated indolyl­fulgides have been determined, namely (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,2‐tri­fluoro­ethyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (tri­fluoro­methyl­iso­propyl­idene­indolyl­fulgide), C₁₉H₁₆F₃NO₃, (I), (3Z)‐3‐[1‐(1,2‐dimethyl‐1H‐indol‐3‐yl)‐2,2,3,3,3‐penta­fluoro­propyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (penta­fluoro­ethyl­iso­propyl­idene­indolyl­fulgide), C₂₀H₁₆F₅NO₃, (II), (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,3,3,4,4,4‐hepta­fluoro­butyl­idene]‐4‐(1‐methyl­ethyl­idene)­dihydrofuran‐2,5‐dione (hepta­fluoro­propyl­iso­propyl­idene­indolyl­fulgide), C₂₁H₁₆F₇NO₃, (III), (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,2‐tri­fluoro­ethyl­idene]‐4‐(tri­cyclo­[3.3.1.1^3,7]­decyl­idene­)dihydrofuran‐2,5‐dione (tri­fluoro­methyl­adamantyl­idene­indolyl­fulgide), C₂₆H₂₄F₃NO₃, (IV), and (3Z)‐3‐[1‐(1,2‐di­methyl‐1H‐indol‐3‐yl)‐2,2,3,3,4,4,4‐hepta­fluoro­butyl­idene]‐4‐(tri­cyclo­[3.3.1.1^3,7]­decyl­idene­)dihydrofuran‐2,5‐dione (hepta­fluoro­propyl­adamantylidenein­dolyl­fulgide), C₂₈H₂₄F₇NO₃, (V). The photochromic property of fulgides is based on the photochemically allowed electrocyclic ring closure of a hexatriene system to form a cyclo­hexa­diene. For each fulgide examined, the bond lengths within the hexatriene system alternate between short and long, as expected. Comparing the structures of the five fulgides with each other demonstrates no significant difference in bond lengths, bond angles or dihedral angles within the hexatriene systems. The distance between the bond‐forming C atoms at each end of the hexatriene system does vary. Correlations of structural properties with optical properties are addressed.     

9,10‐Di­methoxy‐4‐methyl‐1,2‐di­hydro‐1‐aza­anthracen‐2‐one (kalasin­amide), a new aza­anthracene alkaloid

A new aza­anthracene alkaloid, namely 9,10‐di­methoxy‐4‐methyl‐1,2‐di­hydro‐1‐aza­anthracen‐2‐one (kalasin­amide), C₁₆H₁₅NO₃, has been isolated from the stems of Polyal­thia suberosa collected in the northeastern part of Thailand. Each of the aromatic rings in the mol­ecule is planar within 0.021 (2) Å. Molecules are linked to form centrosymmetric dimers by N—H?O hydrogen bonds [N?O 2.941 (4) Å].     

N,N′‐Bis(2‐methoxy­benzyl­idene) adducts of ethane‐1,2‐di­amine,propane‐1,3‐di­amine and butane‐1,4‐di­amine

We have isolated and crystallographically characterized the three homologous compounds N,N′‐bis(2‐methoxy­benzyl­idene)­ethane‐1,2‐di­amine (MeSalen), C₁₈H₂₀N₂O₂, N,N′‐bis(2‐methoxy­benzyl­idene)­propane‐1,3‐di­amine (MeSalpr), C₁₉H₂₂N₂O₂, and N,N′‐bis(2‐methoxy­benzyl­idene)­butane‐1,4‐di­amine (MeSalbu), C₂₀H₂₄N₂O₂. In contrast with MeSalpr, the mol­ecules of MeSalen and MeSalbu, which have an even number of methyl­ene units, have crystallographic symmetry. Comparing these methoxy‐substituted species with their hydroxy equivalents shows that the aryl rings rotate upon removal of the O—H⋯N hydrogen bonds. The packing of MeSalen and MeSalpr is controlled by C—H⋯π interactions, whereas that of MeSalbu has only van der Waals contacts.     

A pentaerythritol‐derived spirodi­phospho­nate

The title spirodi­phospho­nate, 3,9‐di­methyl‐2,4,8,10‐tetraoxa‐3λ⁵,9λ⁵‐diphospha­spiro­[5.5]­un­decane‐3,9‐dione, C₇H₁₄O₆P₂, a polymer additive, has crystallographic symmetry 2. At 100 K, its six‐membered rings have chair conformations, with endocyclic torsion‐angle magnitudes in the range 51.87 (8)–58.93 (9)°. The P=O distance is 1.4749 (8) Å, while the P—C(methyl) distance is 1.7691 (12) Å.     

Two new conformationally restricted 4,5‐dihydroxynorvaline analogues with a norbornane skeleton

The structures of two conformationally restricted 4,5‐di­hydroxy­norvaline analogues with a norbornane skeleton, namely methyl (1S,2S,3R,4R)‐2‐benz­amido‐3‐(1,2‐di­hydroxy­ethyl)­bi­cyclo[2.2.1]­heptane‐2‐carboxyl­ate, C₁₈H₂₃NO₅, and methyl (1R,2S,3R,4S)‐2‐benz­amido‐3‐(1,2‐di­hydroxy­ethyl)­bi­cyclo[2.2.1]­heptane‐2‐carboxyl­ate, C₁₈H₂₃NO₅, exhibit a conformation in the helical region of the ?,ψ map but their handedness is opposite. In both cases, the torsion angles (χ^1,1) giving the relative orientation of the 1,2‐di­hydroxy­ethyl group of the amino acid side chain and the benz­amide group of the peptide chain indicate that these groups adopt a nearly eclipsed conformation. Both compounds show a complex hydrogen‐bonding pattern.     

(Z)‐7‐Chloro‐3‐[(3‐chloro­phenyl)­methyl­idene]‐4‐p‐tosyl‐3,4‐di­hydro‐2H‐1,4‐benzoxazine

In the title compound, C₂₂H₁₇Cl₂NO₃S, the mol­ecule is a substituted 3,4‐di­hydro‐2H‐1,4‐benzoxazine compound which has three phenyl rings which are essentially planar. The 3,4‐di­hydro‐2H‐oxazine part of the mol­ecule is fused to the benzo ring and has a half‐boat conformation; the dihedral angle between the planar part of the oxazine ring and the benzo ring is 10.2 (2)°. The (3‐chloro­phenyl)­methyl­idene substituent has a Z configuration in relation to the ring N atom of the oxazine moiety. Interestingly, the p‐toluenesulfonyl (p‐tosyl) substituent on the ring N atom protrudes away from the 3‐­chloro­phenyl substituent thus avoiding any steric interaction.     

Supramolecular structures of 5‐[3‐(4‐methyl­phenyl)‐ and 5‐[3‐(4‐chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione

2,2‐Di­methyl‐5‐[3‐(4‐methyl­phenyl)‐2‐propenyl­idene]‐1,3‐di­ox­ane‐4,6‐dione, C₁₆H₁₆O₄, crystallizes in the triclinic space group , with two mol­ecules in the asymmetric unit. These mol­ecules and a centrosymmetrically related pair, linked together by weak C—H?O hydrogen bonds, form a tetramer. 5‐[3‐(4‐Chloro­phenyl)‐2‐propenyl­idene]‐2,2‐di­methyl‐1,3‐dioxane‐4,6‐dione, C₁₅H₁₃ClO₄, also crystallizes in the triclinic space group , with one mol­ecule in the asymmetric unit. Centrosymmetrically related mol­ecules are linked together by weak C—H?O hydrogen bonds to form dimers which are further linked by yet another pair of centrosymmetrically related C—H?O hydrogen bonds to form a tube which runs parallel to the a axis.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

An anthracene dimer with a fused 1,3‐dithiole ring at 193 K

The first butterfly‐shaped anthracene dimer including S atoms,8,9‐di­hydro‐3a,8[1′,2′]:9,13b[1′′,2′′]­di­benzeno­dibenzo­[3,4:7,8]cyclo­octa­[1,2‐d]‐1,3‐di­thiole, C₂₉H₂₀S₂, contains an exceptionally long Csp³—Csp³ bond of 1.672 (2) Å in the fused 1,3‐di­thiole ring. The length of the other bond bridging the anthracene moieties is 1.604 (3) Å.     

9,10‐Di­phenyl‐9,10‐epi­dioxy­anthra­cene and 9,10‐di­hydro‐10,10‐di­methoxy‐9‐phenyl­anthracen‐9‐ol

9,10‐Di­phenyl‐9,10‐epi­dioxy­anthracene, C₂₆H₁₈O₂, (I), was accidentally used in a photo­oxy­genation reaction that produced 9,10‐di­hydro‐10,10‐di­methoxy‐9‐phenyl­anthracen‐9‐ol, C₂₂H₂₀O₃, (II). In both compounds, the phenyl rings are approximately orthogonal to the anthracene moiety. The conformation of the anthracene moiety differs as a result of substitution. Intramolecular C—H⃛O interactions in (I) form two approximately planar S(5) rings in each of the two crystallographically independent mol­ecules. The packing of (I) and (II) consists of molecular dimers stabilized by C—H⃛O interactions and of molecular chains stabilized by O—H⃛O interactions, respectively.     

A mol­ecule with a C1‐homobasketane framework

The title compound, 6‐(1,3‐benzodi­thiol‐2‐yl­idene)‐5,7‐di­methyl‐1,2‐di­phenylpenta­cyclo­[5.4.0.0^2,5.0^3,11.0^4,8]­un­decane, C₃₂H₂₈S₂, with a C₁‐homobasketane framework, crystallizes in the P space group with one mol­ecule in the asymmetric unit. The two cyclo­butane rings in the cage are in a puckered conformation. Due to the enhanced through‐bond interaction of the phenyl π systems involving a strained σ bond, the (Ph—­)C—C(—Ph) bond length is significantly extended, to 1.610 (3) Å.     

Charge‐transfer complexes of 4‐(di­methyl­amino)­pyridine with 2,4‐, 3,4‐ and 3,5‐di­nitro­benzoic acid

In the three title crystal structures 4‐(di­methyl­amino)­pyridinium 2,4‐di­nitro­benzoate, (I), 4‐(di­methyl­amino)­pyri­dinium 3,4‐di­nitro­benzo­ate, (II), and 4‐(di­methyl­amino)pyri­din­ium 3,5‐di­nitro­benzo­ate, (III), all C₇H₁₁N₂⁺·C₇H₃N₂O₆^?, the ions are connected by an N—H?O hydrogen bond. Dihedral angles between the pyridine and phenyl rings are 69.9 (1), 26.7 (1) and 56.2 (1)° in (I), (II) and (III), respectively. Donor–acceptor π–π stacking is observed in (II) and (III), but not in (I).     

Two polycyclic compounds derived from a Diels–Alder reaction

In both 9,10‐di­methoxy‐11‐oxatri­cyclo­[6.2.1.0^2,7]­undeca‐4,9‐diene‐3,6‐diol, C₁₂H₁₆O₅, (I), and 5,6‐di­methoxy‐3,7‐dioxa­tetra­cyclo­[6.4.0.0^2,6.0^4,12]­dodec‐9‐en‐11‐ol, C₁₂H₁₆O₅, (II), the hetero‐oxygen‐containing five‐membered rings have an envelope conformation. The six‐membered rings are in a boat conformation in compound (I), and in (II), one is in a half‐boat and the other is in a slightly distorted boat conformation. The mol­ecules in both compounds interact through classical hydrogen bonds and C—H?O contacts.     

Berberine formate–succinic acid (1/1)

The title compound [systematic name: 9,10‐di­methoxy‐2,3‐methyl­ene­dioxy‐5,6‐di­hydro­dibenzo­[a,g]­quinolizinium form­ate–succinic acid (1/1)], C₂₀H₁₈NO₄⁺·CHO₂⁻·C₄H₆O₄, con­tains centrosymmetric pairs of almost planar berberine cations, and hydrogen‐bonded (C₄H₆O₄⋯HCOO⁻)₂ rings of succinic acid with formate anions, bonded by O—H⋯O hydrogen bonds with O⋯O distances of 2.4886 (15) and 2.5652 (16) Å. Pairs of cations and mol­ecules of succinic acid are connected by non‐conventional weak C—H⋯O hydrogen bonds, with C⋯O distances of 3.082 (2) and 3.178 (2) Å.     

The salt‐type 1:2 adduct of meso‐5,5,7,12,12,14‐hexa‐C‐methyl‐1,4,8,11‐tetraazacyclotetradecane (tet‐a) and 5‐nitroisophthalic acid forms a hydrogen‐bonded sheet ­structure containing two configur­ational isomers of [(tet‐a)H2]2+

The title compound, meso‐5,7,7,12,14,14‐hexa­methyl‐4,11‐di­aza‐1,8‐diazo­nia­cyclo­tetra­decane bis(3‐carboxy‐5‐nitro­benz­oate), C₁₆H₃₈N₄²⁺·2C₈H₄NO₆^?, is a salt in which the cation is present as two configurational isomers, disordered across a common centre of inversion in P, with occupancies of 0.847 (3) and 0.153 (3). The anions are linked into chains by a single O—H?O hydrogen bond [H?O 1.71 Å, O?O 2.5063 (15) Å and O—H?O 156°] and the cations link these anion chains into sheets by means of a range of N—H?O hydrogen bonds [H?O 1.81–2.53 Å, N?O 2.718 (5)–3.3554 (19) Å and N—H?O 146–171°].     

A stacked pyrazolo[3,4‐d]pyrimidine‐based flexible molecule: the effect of a bulky benzyl group on intermolecular stacking in comparison with methyl and ethyl groups

In the crystal structure of 1,1′‐(1,3‐propane­diyl)­bis(5‐benzyl‐6‐methyl­sulfanyl‐4,5‐di­hydro‐1H‐pyrazolo­[3,4‐d]­pyrimidin‐4‐one), C₂₉H₂₈N₈O₂S₂, the pairs of pyrazolo­[3,4‐d]­pyrimidine rings stack as a result of intramolecular π–π interactions between the heterocyclic rings. The folded mol­ecules are further stacked in pairs, due to intermolecular aromatic π–π interactions and C—H?O hydrogen bonds.     

Three‐dimensional aggregation in 2‐hydroxy‐3‐iodo‐5‐nitrobenzaldehyde involving C—H⋯O,iodo–nitro and aromatic π–π stacking interactions,and isolated dimers in disordered 2,4‐diiodo‐6‐nitroanisole

In 2‐hydroxy‐3‐iodo‐5‐nitro­benz­aldehyde, C₇H₄INO₄, the mol­ecules are linked into sheets by a combination of C—H⋯O hydrogen bonds and two‐centre iodo–nitro interactions, and these sheets are linked by aromatic π–π stacking interactions. Molecules of 2,4‐di­iodo‐6‐nitro­anisole, C₇H₅I₂NO₃, are disordered, with the nitro group and one of the I substituents each occupying common sets of sites with 0.5 occupancy. The mol­ecules are linked into isolated centrosymmetric dimeric units by a single iodo–nitro interaction.     

Amino­pyrimidine–carboxyl­(ate) interactions in trimethoprim maleate,an antifolate drug

In the title cocrystal, trimethoprim maleate [2,4‐di­amino‐5‐(3,4,5‐tri­methoxy­benzyl)­pyrimidin‐1‐ium maleate], C₁₄H₁₉­N₄O₃⁺·­C₄H₃O₄^?, the trimethoprim mol­ecule is protonated at N1. The carboxyl group of the maleate ion makes a specific double hydrogen bond of type N—H?O with the 2‐amino group and the protonated N1 atom of the trimethoprim cation which is similar to the carboxyl­ate–trimethoprim cation interaction observed in the complex of di­hydro­folate reductase with trimethoprim. The pyrimidine moieties of trimethoprim cations are centrosymmetrically paired through a pair of N—H?N hydrogen bonds involving the 4‐amino group and the pyridinium N3 atom of a symmetry‐related molecule. One of the O atoms at the maleate carboxyl­ate group bridges the 2‐­amino and 4‐amino groups on either side of the paired trimethoprim cations. The other O atom of the carboxyl­ate group forms an intramolecular O—H?O hydrogen bond with the carboxyl group. These characteristic hydrogen bonds result in infinite two‐dimensional aggregation of rings into a supramolecular ladder, which is further crosslinked through weak C—H?O interactions with methoxy groups of neighbouring trimethoprim mol­ecules to form a layered structure.     

Three methoxy‐substituted diethyl 4‐­phenyl‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate compounds

Diethyl 4‐(2,5‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (I), diethyl 4‐(3,4‐di­methoxy­phenyl)‐2,6‐di­methyl‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₁H₂₇NO₆, (II), and diethyl 2,6‐di­methyl‐4‐(3,4,5‐tri­methoxy­phenyl)‐1,4‐di­hydro­pyridine‐3,5‐di­carboxyl­ate, C₂₂H₂₉NO₇, (III), crystallize with hydrogen‐bonding networks involving the H atom bonded to the N atom of the 1,4‐di­hydro­pyridine ring and carbonyl O atoms in (I) and (II). Unusually, (III) shows O atoms of methoxy groups serving as hydrogen‐bond acceptors.     

Di­cyclo­hexyl­ammonium 2,4‐di­chloro­phenoxy­acetate and (2,4‐di­chloro­phenoxy­acetato‐O,O′)bis­(tri­phenylphosphine‐P)silver(I)

The monoclinic cell of di­cyclo­hexyl­ammonium 2,4‐di­chloro­phenoxy­acetate contains four C₁₂H₂₄N⁺·C₅H₈Cl₂O₃^? ion pairs. The ammonium N atom is hydrogen bonded to the oxy­gen ends of two carboxyl groups to form a 12‐membered O—C—O?HNH?O—C—O?HNH ring. In (2,4‐di­chloro­phenoxy­lacetato)­bis­(tri­phenyl­phosphine)silver(I), [Ag(C₈H₅Cl₂O₃)(C₁₈H₁₅P)₂], the carboxyl CO₂ unit chelates to the Ag atom in an anisobidentate manner [Ag—O = 2.436 (2) and 2.517 (2) Å]; the Ag atom shows distorted tetrahedral geometry.